1. Home
  2. CRON vs BCX Comparison

CRON vs BCX Comparison

Compare CRON & BCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRON
  • BCX
  • Stock Information
  • Founded
  • CRON 2012
  • BCX 2011
  • Country
  • CRON Canada
  • BCX United States
  • Employees
  • CRON N/A
  • BCX N/A
  • Industry
  • CRON Medicinal Chemicals and Botanical Products
  • BCX Finance/Investors Services
  • Sector
  • CRON Health Care
  • BCX Finance
  • Exchange
  • CRON Nasdaq
  • BCX Nasdaq
  • Market Cap
  • CRON 804.7M
  • BCX 787.2M
  • IPO Year
  • CRON N/A
  • BCX N/A
  • Fundamental
  • Price
  • CRON $2.01
  • BCX $9.09
  • Analyst Decision
  • CRON Hold
  • BCX
  • Analyst Count
  • CRON 2
  • BCX 0
  • Target Price
  • CRON $3.00
  • BCX N/A
  • AVG Volume (30 Days)
  • CRON 1.5M
  • BCX 370.6K
  • Earning Date
  • CRON 11-12-2024
  • BCX 01-01-0001
  • Dividend Yield
  • CRON N/A
  • BCX 6.99%
  • EPS Growth
  • CRON N/A
  • BCX N/A
  • EPS
  • CRON N/A
  • BCX N/A
  • Revenue
  • CRON $111,229,000.00
  • BCX N/A
  • Revenue This Year
  • CRON $29.92
  • BCX N/A
  • Revenue Next Year
  • CRON $16.92
  • BCX N/A
  • P/E Ratio
  • CRON N/A
  • BCX N/A
  • Revenue Growth
  • CRON 30.31
  • BCX N/A
  • 52 Week Low
  • CRON $1.85
  • BCX $8.25
  • 52 Week High
  • CRON $3.14
  • BCX $9.90
  • Technical
  • Relative Strength Index (RSI)
  • CRON 42.95
  • BCX 34.81
  • Support Level
  • CRON $1.91
  • BCX $9.14
  • Resistance Level
  • CRON $2.34
  • BCX $9.27
  • Average True Range (ATR)
  • CRON 0.11
  • BCX 0.12
  • MACD
  • CRON -0.01
  • BCX -0.04
  • Stochastic Oscillator
  • CRON 23.26
  • BCX 1.85

About CRON Cronos Group Inc. Common Share

Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the US, the company has an option to acquire 5.9% of US multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.

About BCX BlackRock Resources of Beneficial Interest

BlackRock Resources & Commodities Strategy Trust operates as an investment trust. Its investment objective is to seek high current income and current gains, with a secondary objective of capital appreciation. The company invests at least 80% of its total assets in equity securities issued by commodity or natural resources companies, derivatives with exposure to commodity or natural resources companies or investments in securities and derivatives linked to the underlying price movement of commodities or natural resources.

Share on Social Networks: